Skip to main content
Log in

Meta-analysis of antidepressants in fibromyalgia

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Conclusions

The authors noted significant study limitations to the studies of TCA including lack of trials using standard antidepressant doses, short study duration, lack of adequate measures of mood disorder, and small sample sizes. The authors suggest double-blind, placebo-controlled, parallel-group studies of sufficient sample size and adequate duration. In addition, if agents with antidepressant activities are studied, adequate assessment of mood disorders is critical. Standardized outcome measures, including physical functioning and quality of life, should be included.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crofford, L.J. Meta-analysis of antidepressants in fibromyalgia. Curr Rheumatol Rep 3, 172 (2001). https://doi.org/10.1007/s11926-001-0013-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-001-0013-6

Keywords

Navigation